Nasus Pharma Ltd (NSRX) Return on equity
Nasus Pharma Ltd (NSRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-211.6%FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -211.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NSRX financial trends
NSRX RevenueNSRX Net incomeNSRX Net marginNSRX Gross profitNSRX Gross marginNSRX Operating incomeNSRX Operating marginNSRX Operating cash flowNSRX Free cash flowNSRX Capital expendituresNSRX Stock buybacksNSRX Dividends paidNSRX Total assetsNSRX Total liabilitiesNSRX Shareholders’ equityNSRX overview →